| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $1,691,857 ) |
| 2024 | 2024 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 000 | 5 | 1/29/2024 | NON-COMPETING CONTINUATION | $1,602,810 |
| 2024 | 2024 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 001 | 5 | 4/16/2024 | NON-COMPETING CONTINUATION | $89,047 |
|
 | Issue Date FY: 2023 ( Subtotal = $1,745,006 ) |
| 2023 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 000 | 4 | 1/4/2023 | NON-COMPETING CONTINUATION | $1,602,555 |
| 2023 | 2023 | VANDERBILT UNIVERSITY | 110 21ST AVE S | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 001 | 4 | 3/16/2023 | NON-COMPETING CONTINUATION | $142,451 |
|
 | Issue Date FY: 2022 ( Subtotal = $1,745,733 ) |
| 2022 | 2022 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 001 | 3 | 5/23/2022 | NON-COMPETING CONTINUATION | $142,510 |
| 2022 | 2022 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 000 | 3 | 12/30/2021 | NON-COMPETING CONTINUATION | $1,603,223 |
|
 | Issue Date FY: 2021 ( Subtotal = $1,782,485 ) |
| 2021 | 2021 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 000 | 2 | 1/29/2021 | NON-COMPETING CONTINUATION | $1,782,485 |
|
 | Issue Date FY: 2020 ( Subtotal = $1,793,739 ) |
| 2020 | 2020 | VANDERBILT UNIVERSITY, THE | 110 21ST AVENUE S STE 800 | NASHVILLE | TN | 37203 | DAVIDSON | USA | Cancer Biology Research | 000 | 1 | 1/22/2020 | NEW | $1,793,739 |
|
|